Assessment In Vitro of a Novel Therapeutic Strategy for Glioma, Combining Herpes Simplex Virus HSV1716-mediated Oncolysis with Gene Transfer and Targeted Radiotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|1|5|423-429

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.1, Iss.5, 2005-09, pp. : 423-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma

By  

Current Gene Therapy, Vol. 9, Iss. 5, 2009-10 ,pp. : 356-367

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Delivery of Growth Factors by HSV-Mediated Gene Transfer for Peripheral Neuropathy

By  

Current Gene Therapy, Vol. 13, Iss. 5, 2013-01 ,pp. : 315-321

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Engineered, Naturally Oncolytic Herpes Simplex Virus HSV1 HF-10:Applications for Cancer Gene Therapy

By  

Current Gene Therapy, Vol. 8, Iss. 3, 2008-06 ,pp. : 208-221

Bentham Science Publishers

Access to resources Recommend Favorite

Immune Response to Herpes Simplex Virus and &ggr;134.5 Deleted HSV Vectors

By  

Current Gene Therapy, Vol. 5, Iss. 5, 2005-10 ,pp. : 523-530

Bentham Science Publishers

Access to resources Recommend Favorite

Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application

By  

Current Gene Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 13-26

Bentham Science Publishers

Access to resources Recommend Favorite